Evaluation of the effectiveness of a peptide-cytokine agent in the complex therapy of recurrent candidal vulvovaginitis
Background. The literature shows that up to 75% of women of reproductive age suffer at least one episode of acute candidal vulvovaginitis (CVV) in life, up to 45% report 2 cases or more, up to 20% experience recurrent (often complicated) course of this disease. Recurrent CVV requires a non-standard...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Berlin A.V.
2024-12-01
|
| Series: | Гинекология |
| Subjects: | |
| Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/643246/159193 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|